M Mino-Kenudson
Overview
Explore the profile of M Mino-Kenudson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
470
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin J, Liu S, McCoach C, Zhu V, Tan A, Yoda S, et al.
Ann Oncol
. 2020 Oct;
31(12):1725-1733.
PMID: 33007380
Background: Rearranged during transfection (RET) gene fusions are a validated target in non-small-cell lung cancer (NSCLC). RET-selective inhibitors selpercatinib (LOXO-292) and pralsetinib (BLU-667) recently demonstrated favorable antitumor activity and safety...
2.
Ciprani D, Morales-Oyarvide V, Qadan M, Hank T, Weniger M, Harrison J, et al.
Pancreatology
. 2020 Apr;
20(4):729-735.
PMID: 32332003
Background: Current guidelines for IPMN include an elevated serum carbohydrate antigen (CA) 19-9 among the worrisome features. However, the correlation of CA 19-9 with histological malignant features and survival is...
3.
Gainor J, Rizvi H, Jimenez Aguilar E, Skoulidis F, Yeap B, Naidoo J, et al.
Ann Oncol
. 2020 Feb;
31(3):404-411.
PMID: 32067682
Background: Immune checkpoint inhibitors (ICIs) are standard therapies for patients with advanced non-small-cell lung cancer (NSCLC) and a programmed death-ligand 1 (PD-L1) tumor proportion score (TPS) ≥50%. Tumor mutation burden...
4.
Sahora K, Crippa S, Zamboni G, Ferrone C, Warshaw A, Lillemoe K, et al.
Eur J Surg Oncol
. 2015 Dec;
42(2):197-204.
PMID: 26687069
Background: Intraductal papillary mucinous neoplasms (IPMN) have been reported to be associated with concurrent, distinct pancreatic ductal adenocarcinoma (con-PDAC) in about 8% (range, 4-10%) of resected branch duct (BD) lesions....
5.
Kotani H, Ebi H, Kitai H, Nanjo S, Kita K, Huynh T, et al.
Oncogene
. 2015 Nov;
35(27):3587-97.
PMID: 26549034
Targeted therapies are effective in subsets of lung cancers with EGFR mutations and anaplastic lymphoma kinase (ALK) translocations. Large-scale genomics have recently expanded the lung cancer landscape with FGFR1 amplification...
6.
Perez-Johnston R, Narin O, Mino-Kenudson M, Ingkakul T, Warshaw A, Fernandez-Del Castillo C, et al.
Pancreatology
. 2013 Feb;
13(1):43-7.
PMID: 23395569
Unlabelled: The frequency and significance of calcification in intraductal papillary mucinous neoplasms (IPMN) are unknown. We examined calcifications by computed tomography (CT) in a large cohort of IPMNs and correlated...
7.
Shaw A, Varghese A, Solomon B, Costa D, Novello S, Mino-Kenudson M, et al.
Ann Oncol
. 2012 Aug;
24(1):59-66.
PMID: 22887466
Background: Anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer (NSCLC) is highly responsive to crizotinib. To determine whether ALK-positive NSCLC is also sensitive to pemetrexed, we retrospectively evaluated progression-free survival (PFS)...
8.
Sequist L, Heist R, Shaw A, Fidias P, Rosovsky R, Temel J, et al.
Ann Oncol
. 2011 Nov;
22(12):2616-2624.
PMID: 22071650
Background: Personalizing non-small-cell lung cancer (NSCLC) therapy toward oncogene addicted pathway inhibition is effective. Hence, the ability to determine a more comprehensive genotype for each case is becoming essential to...
9.
Kang D, Suter M, Boudoux C, Yachimski P, Puricelli W, Nishioka N, et al.
J Microsc
. 2010 Jul;
239(2):87-91.
PMID: 20629914
Spectrally encoded confocal microscopy and optical frequency domain imaging are two non-contact optical imaging technologies that provide images of tissue cellular and architectural morphology, which are both used for histopathological...
10.
Matthes K, Sahani D, Holalkere N, Mino-Kenudson M, Brugge W
Endoscopy
. 2007 Feb;
39 Suppl 1:E3-4.
PMID: 17285498
No abstract available.